Retraction: MicroRNA-217 regulates WASF3 expression and suppresses tumor growth and metastasis in osteosarcoma (PLoS ONE (2014) 9:10 (e109138) DOI: 10.1371/journal.pone.0109138);MicroRNA-217 regulates WASF3 expression and suppresses tumor growth and metastasis in Osteosarcoma

PLoS ONE

Volumn 9, Issue 10, 2014, Pages

  Shen, Lei ^a   Wang, Peng ^b   Yang, Jili ^c   Li, Xiaotao ^d  

^a Qiqihar Medical School   (China)

^b HARBIN MEDICAL UNIVERSITY   (China)

^c Jilin Province Tumor Hospital   (China)

^d JIAMUSI UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

LUCIFERASE; MICRORNA; MICRORNA 217; ONCOPROTEIN; PROTEIN WASF3; UNCLASSIFIED DRUG; 3' UNTRANSLATED REGION; MESSENGER RNA; MIRN217 MICRORNA, HUMAN; WISKOTT ALDRICH SYNDROME PROTEIN;

3' UNTRANSLATED REGION; ADOLESCENT; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; FEMALE; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; OPEN READING FRAME; OSTEOSARCOMA; BINDING SITE; BONE TUMOR; CELL MOTION; CHEMISTRY; GENE EXPRESSION; GENETICS; METASTASIS; NUCLEOTIDE SEQUENCE; PATHOLOGY; TUMOR CELL LINE; TUMOR VOLUME;

3' UNTRANSLATED REGIONS; BASE SEQUENCE; BINDING SITES; BONE NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; DOWN-REGULATION; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; NEOPLASM METASTASIS; OSTEOSARCOMA; RNA, MESSENGER; TUMOR BURDEN; WISKOTT-ALDRICH SYNDROME PROTEIN FAMILY;

EID: 84907841904     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0269901     Document Type: Erratum

References (35)

1. Yang J, Zhang W (2013) New molecular insights into osteosarcoma targeted therapy. Curr Opin Oncol 25:398-406.
2. Ji F, Zhang H, Wang Y, Li M, Xu W, et al. (2013) MicroRNA-133a, downregulated in osteosarcoma, suppresses proliferation and promotes apoptosis by targeting Bcl-xL and Mcl-1. Bone 56:220-226.
3. Gougelet A, Pissaloux D, Besse A, Perez J, Duc A, et al. (2011) Micro-RNA profiles in osteosarcoma as a predictive tool for ifosfamide response. Int J Cancer 129:680-690.
4. Kobayashi E, Hornicek FJ, Duan Z (2012) MicroRNA Involvement in Osteosarcoma. Sarcoma 2012:359739.
5. Van Wynsberghe PM, Chan SP, Slack FJ, Pasquinelli AE (2011) Analysis of microRNA expression and function. Methods Cell Biol 106:219-252.
6. Liang W, Gao B, Fu P, Xu S, Qian Y, et al. (2013) The miRNAs in the pathgenesis of osteosarcoma. Front Biosci (Landmark Ed) 18:788-794.
7. Tang JT, Fang JY (2009) MicroRNA regulatory network in human colorectal cancer. Mini Rev Med Chem 9:921-926.
8. Suzuki H, Maruyama R, Yamamoto E, Kai M (2012) DNA methylation and microRNA dysregulation in cancer. Mol Oncol.
9. Song B, Ju J (2010) Impact of miRNAs in gastrointestinal cancer diagnosis and prognosis. Expert Rev Mol Med 12:e33.
10. Schotte D, Pieters R, Den Boer ML (2012) MicroRNAs in acute leukemia: from biological players to clinical contributors. Leukemia 26:1-12.
11. Sandoval J, Esteller M (2012) Cancer epigenomics: beyond genomics. Curr Opin Genet Dev 22:50-55.
12. Rottiers V, Najafi-Shoushtari SH, Kristo F, Gurumurthy S, Zhong L, et al. (2011) MicroRNAs in metabolism and metabolic diseases. Cold Spring Harb Symp Quant Biol 76:225-233.
13. Qi J, Yu JY, Shcherbata HR, Mathieu J, Wang AJ, et al. (2009) microRNAs regulate human embryonic stem cell division. Cell Cycle 8:3729-3741.
14. Li H, Zhao J, Zhang JW, Huang QY, Huang JZ, et al. (2013) MicroRNA-217, down-regulated in clear cell renal cell carcinoma and associated with lower survival, suppresses cell proliferation and migration. Neoplasma 60:511-515.
15. Zhao WG, Yu SN, Lu ZH, Ma YH, Gu YM, et al. (2010) The miR-217 microRNA functions as a potential tumor suppressor in pancreatic ductal adenocarcinoma by targeting KRAS. Carcinogenesis 31:1726-1733.
16. Kato M, Putta S, Wang M, Yuan H, Lanting L, et al. (2009) TGF-beta activates Akt kinase through a microRNA-dependent amplifying circuit targeting PTEN. Nat Cell Biol 11:881-889.
17. Menghini R, Casagrande V, Cardellini M, Martelli E, Terrinoni A, et al. (2009) MicroRNA 217 modulates endothelial cell senescence via silent information regulator 1. Circulation 120:1524-1532.
18. Li Z, Lei H, Luo M, Wang Y, Dong L, et al. (2014) DNA methylation downregulated mir-10b acts as a tumor suppressor in gastric cancer. Gastric Cancer.
19. Miao J, Wu S, Peng Z, Tania M, Zhang C (2013) MicroRNAs in osteosarcoma: diagnostic and therapeutic aspects. Tumour Biol.
20. Jones KB, Salah Z, Del Mare S, Galasso M, Gaudio E, et al. (2012) miRNA signatures associate with pathogenesis and progression of osteosarcoma. Cancer Res 72:1865-1877.
21. Dai N, Zhong ZY, Cun YP, Qing Y, Chen C, et al. (2013) Alteration of the microRNA expression profile in human osteosarcoma cells transfected with APE1 siRNA. Neoplasma 60:384-394.
22. Chen L, Wang Q, Wang GD, Wang HS, Huang Y, et al. (2013) miR-16 inhibits cell proliferation by targeting IGF1R and the Raf1-MEK1/2-ERK1/2 pathway in osteosarcoma. FEBS Lett 587:1366-1372.
23. Won KY, Kim YW, Kim HS, Lee SK, Jung WW, et al. (2013) MicroRNA-199b-5p is involved in the Notch signaling pathway in osteosarcoma. Hum Pathol 44:1648-1655.
24. Ouyang L, Liu P, Yang S, Ye S, Xu W, et al. (2013) A three-plasma miRNA signature serves as novel biomarkers for osteosarcoma. Med Oncol 30:340.
25. Mao JH, Zhou RP, Peng AF, Liu ZL, Huang SH, et al. (2012) microRNA-195 suppresses osteosarcoma cell invasion and migration in vitro by targeting FASN. Oncol Lett 4:1125-1129.
26. Zhao G, Cai C, Yang T, Qiu X, Liao B, et al. (2013) MicroRNA-221 induces cell survival and cisplatin resistance through PI3K/Akt pathway in human osteosarcoma. PLoS One 8:e53906.
27. Zhao H, Guo M, Zhao G, Ma Q, Ma B, et al. (2012) miR-183 inhibits the metastasis of osteosarcoma via downregulation of the expression of Ezrin in F5M2 cells. Int J Mol Med 30:1013-1020.
28. Zhu J, Feng Y, Ke Z, Yang Z, Zhou J, et al. (2012) Down-regulation of miR-183 promotes migration and invasion of osteosarcoma by targeting Ezrin. Am J Pathol 180:2440-2451.
29. Wu X, Zhong D, Gao Q, Zhai W, Ding Z, et al. (2013) MicroRNA-34a inhibits human osteosarcoma proliferation by downregulating ether a go-go 1 expression. Int J Med Sci 10:676-682.
30. Song L, Yang J, Duan P, Xu J, Luo X, et al. (2013) MicroRNA-24 inhibits osteosarcoma cell proliferation both in vitro and in vivo by targeting LPAATbeta. Arch Biochem Biophys 535:128-135.
31. Teng Y, Mei Y, Hawthorn L, Cowell JK (2014) WASF3 regulates miR-200 inactivation by ZEB1 through suppression of KISS1 leading to increased invasiveness in breast cancer cells. Oncogene 33:203-211.
32. Teng Y, Ghoshal P, Ngoka L, Mei Y, Cowell JK (2013) Critical role of the WASF3 gene in JAK2/STAT3 regulation of cancer cell motility. Carcinogenesis 34:1994-1999.
33. Teng Y, Ren MQ, Cheney R, Sharma S, Cowell JK (2010) Inactivation of the WASF3 gene in prostate cancer cells leads to suppression of tumorigenicity and metastases. Br J Cancer 103:1066-1075.
34. Teng Y, Liu M, Cowell JK (2011) Functional interrelationship between the WASF3 and KISS1 metastasis-associated genes in breast cancer cells. Int J Cancer 129:2825-2835.
35. Ghoshal P, Teng Y, Lesoon LA, Cowell JK (2012) HIF1A induces expression of the WASF3 metastasis-associated gene under hypoxic conditions. Int J Cancer 131:E905-915.